Skip to main content

Table 4 Characteristics of the study groups according to comorbid asthma

From: Can nasal nitric oxide be a biomarker to differentiate allergic and non-allergic rhinitis?

 

AR (n, 289)

AR+A (n, 48)

NAR (n, 93)

NAR+A (n, 13)

P value

Age

25 (21-33)

27 (20-35)

27 (21-35)

45 (32-58)

0.001#

BMI

23.8 ± 4.4

23.3 ± 4.4

23.8 ± 4.4

23.8 ± 4.4

0.121*

TNSS

6.8 ± 3.01

6.4 ± 2.7

5.4 ± 2.6

5.1 ± 2.4

0.064*

Rhinitis duration (year)

5 (2-9)

5 (3-10)

3 (2-7)

9 (2-21)

0.013#

nNO

380 (223-565)

315 (159-504)

309 (135-445)

121 (69-254)

< 0.001#

  1. AR allergic rhinitis, NAR non-allergic rhinitis, AR+A allergic rhinitis + asthma, NAR+A non-allergic rhinitis + asthma, BMI body mass index, TNSS total nasal symptoms score, *One-way ANOVA test, #Kruskal-Wallis test, according to post hoc analysis, p values in bold are significant